This company seems to have been delisted
Reason: Rebranded as Zevra Therapeutics
Last recorded trade on: May 3, 2023
Source: https://www.mmm-online.com/home/channel/kempharm-rebrands-to-zevra-therapeutics-doubling-down-on-rare-disease-focus/
Reason: Rebranded as Zevra Therapeutics
Last recorded trade on: May 3, 2023
Source: https://www.mmm-online.com/home/channel/kempharm-rebrands-to-zevra-therapeutics-doubling-down-on-rare-disease-focus/
KemPharm
KMPH
NZ$9.75
Share price
-0.34%
Change (1 day)
5.57%
Change (1 year)
Categories
KemPharm (KMPH) - Total debt
Total debt on the balance sheet as of December 2022 : NZ$38.78 Million
According to KemPharm's latest financial reports the company's total debt is NZ$38.78 Million. A company’s total debt is the sum of all current and non-current debts.
KemPharm - Total debt on balance sheet (from 2014 to 2022)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | NZ$36.41 M | 1445.67% |
| 2021-12-31 | NZ$2.35 M | -97.59% |
| 2020-12-31 | NZ$97.77 M | -17.2% |
| 2019-12-31 | NZ$0.11 B | -3.46% |
| 2018-12-31 | NZ$0.12 B | -7.07% |
| 2017-12-31 | NZ$0.13 B | -0.16% |
| 2016-12-31 | NZ$0.13 B | 290.65% |
| 2015-12-31 | NZ$33.74 M | 45.72% |
| 2014-12-31 | NZ$23.16 M | 379.39% |
| 2013-12-31 | NZ$4.83 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Jazz Pharmaceuticals JAZZ | NZ$9.09 B | 23,344.65% | 🇮🇪 Ireland |
 Agile Therapeutics
AGRX | NZ$0.48 M | -98.75% | 🇺🇸 USA |
 Theravance Biopharma
TBPH | NZ$80.8 M | 108.31% | Cayman Islands |
 ANI Pharmaceuticals ANIP | NZ$1.04 B | 2,594.22% | 🇺🇸 USA |